La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion: Comparison with 5-HT2A Receptor Functional Activity
Darya V. Bazovkina, Elena M. Kondaurova, Vladimir S. Naumenko and Evgeni Ponimaskin Neural Plasticity 2015 1 (2015) https://doi.org/10.1155/2015/846589
Serotonin Receptor 2C -759C/T Polymorphism and Weight Change or Treatment Response to Mirtazapine in Korean Depressive Patients
The mechanism, efficacy, and tolerability profile of agomelatine
Sarah E MacIsaac, André F Carvalho, Danielle S Cha, Rodrigo B Mansur and Roger S McIntyre Expert Opinion on Pharmacotherapy 15(2) 259 (2014) https://doi.org/10.1517/14656566.2014.862233
On ‘polypharmacy’ and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal
Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists
Roberta Galeazzi, Luca Massaccesi, Francesco Piva, Giovanni Principato and Emilioano Laudadio Journal of Molecular Modeling 20(3) (2014) https://doi.org/10.1007/s00894-014-2120-0
Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice
Fabiana K. Ludka, Leandra Celso Constantino, Gislaine Kuminek, et al. Pharmacology Biochemistry and Behavior 122 253 (2014) https://doi.org/10.1016/j.pbb.2014.04.005
Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment
A unique gene expression signature associated with serotonin 2C receptor RNA editing in the prefrontal cortex and altered in suicide
Antonio Fabio Di Narzo, Alexey Kozlenkov, Panos Roussos, et al. Human Molecular Genetics 23(18) 4801 (2014) https://doi.org/10.1093/hmg/ddu195
Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA‐A receptor tone in the substantia nigra
Mary V. Burke, Christine Nocjar, Alex J. Sonneborn, Andrew C. McCreary and Elizabeth A. Pehek Journal of Neurochemistry 131(4) 432 (2014) https://doi.org/10.1111/jnc.12842
Use of second generation antipsychotics for treatment-resistant major depressive disorder
Gq/5-HT
2c
receptor signals activate a local GABAergic inhibitory feedback circuit to modulate serotonergic firing and anxiety in mice
Katharina Spoida, Olivia A. Masseck, Evan S. Deneris and Stefan Herlitze Proceedings of the National Academy of Sciences 111(17) 6479 (2014) https://doi.org/10.1073/pnas.1321576111
Novel tricyclic[2,1-f]theophylline derivatives of LCAP with activity in mouse models of affective disorders
Anna Partyka, Jakub Jarosz, Anna Wasik, Magdalena Jastrzębska-Więsek, Agnieszka Zagórska, Maciej Pawłowski and Anna Wesołowska Journal of Pharmacy and Pharmacology 66(12) 1755 (2014) https://doi.org/10.1111/jphp.12305
Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects
Christiana Villela de Andrade Strauss, Maria Adrielle Vicente and Helio Zangrossi Behavioural Brain Research 246 103 (2013) https://doi.org/10.1016/j.bbr.2013.03.005
Role of 5-HT2C receptors in the enhancement of c-Fos expression induced by a 5-HT2B/2C inverse agonist and 5-HT2 agonists in the rat basal ganglia
Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model
Systematic review, structural analysis, and new theoretical perspectives on the role of serotonin and associated genes in the etiology of psychopathy and sociopathy
Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease
Sylvia Navailles, Mélanie Lagière, Audrey Roumegous, et al. International Journal of Neuropsychopharmacology 16(3) 593 (2013) https://doi.org/10.1017/S1461145712000417
Serotoninergic agonists and antagonists are the modulators of α1-Adrenoceptor activity in rat brain cortical membranes
Design, Synthesis, and Pharmacological Characterization of N- and O-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2C Receptor Agonists with Pro-Cognitive Properties
Anders A. Jensen, Niels Plath, Martin H. F. Pedersen, Vignir Isberg, Jacob Krall, Petrine Wellendorph, Tine B. Stensbøl, David E. Gloriam, Povl Krogsgaard-Larsen and Bente Frølund Journal of Medicinal Chemistry 56(3) 1211 (2013) https://doi.org/10.1021/jm301656h
The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania
5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus
Valquíria Camin de Bortoli, Paula Shimene de Melo Yamashita and Hélio Zangrossi Journal of Psychopharmacology 27(12) 1116 (2013) https://doi.org/10.1177/0269881113492900
Serotonin receptors involved in antidepressant effects
Serotonin 2c receptor RNA editing in major depression and suicide
Rebecca Lyddon, Andrew J. Dwork, Mehdi Keddache, Larry J. Siever and Stella Dracheva The World Journal of Biological Psychiatry 14(8) 590 (2013) https://doi.org/10.3109/15622975.2011.630406
Diverse effects of 5-HT2C receptor blocking agents on c-Fos expression in the rat basal ganglia
S32212, a Novel Serotonin Type 2C Receptor Inverse Agonist/α2-Adrenoceptor Antagonist and Potential Antidepressant: II. A Behavioral, Neurochemical, and Electrophysiological Characterization
Anne Dekeyne, Mauricette Brocco, Florence Loiseau, Alain Gobert, Jean-Michel Rivet, Benjamin Di Cara, Thomas I. Cremers, Gunnar Flik, Kevin C.F. Fone, David J.G. Watson, Mariusz Papp, Trevor Sharp, Florence Serres, Raymond Cespuglio, Berend Olivier, Johnny S.W. Chan, Gilbert Lavielle and Mark J. Millan The Journal of Pharmacology and Experimental Therapeutics 340(3) 765 (2012) https://doi.org/10.1124/jpet.111.187534
The anxiogenic-like effects of dehydration in a semi-desert rodent Meriones shawi indicating the possible involvement of the serotoninergic system
S32212, a Novel Serotonin Type 2C Receptor Inverse Agonist/α2-Adrenoceptor Antagonist and Potential Antidepressant: I. A Mechanistic Characterization
Mark J. Millan, Clotilde Mannoury la Cour, Benjamin Chanrion, Delphine S. Dupuis, Benjamin Di Cara, Valérie Audinot, Didier Cussac, Adrian Newman-Tancredi, Maud Kamal, Jean A. Boutin, Ralf Jockers, Philippe Marin, Joël Bockaert, Olivier Muller, Anne Dekeyne and Gilbert Lavielle The Journal of Pharmacology and Experimental Therapeutics 340(3) 750 (2012) https://doi.org/10.1124/jpet.111.187468
Envolvimento de receptores 5-HT2C do hipocampo ventral em comportamentos de defesa de ratos no labirinto em cruz elevado
Marília Greidinger Carvalho, Graziela Furtado Scarpelli Ferreira, Marcelo de Faria Salviano, et al. Estudos de Psicologia (Natal) 17(1) 145 (2012) https://doi.org/10.1590/S1413-294X2012000100018
5-HT2C Receptors in the Pathophysiology of CNS Disease
Drug discovery targeting human 5-HT2C receptors: Residues S3.36 and Y7.43 impact ligand—Binding pocket structure via hydrogen bond formation
Clinton E. Canal, Tania C. Cordova-Sintjago, Nancy Y. Villa, Li-Juan Fang and Raymond G. Booth European Journal of Pharmacology 673(1-3) 1 (2011) https://doi.org/10.1016/j.ejphar.2011.10.006
Mode of action of agomelatine: Synergy between melatonergic and 5-HT2C receptors
Vincent J. Aloyo, Kelly A. Berg, William P. Clarke, Umberto Spampinato and John A. Harvey Progress in Molecular Biology and Translational Science, Membrane Proteins as Drug Targets 91 1 (2010) https://doi.org/10.1016/S1877-1173(10)91001-6
5‐HT2C receptor activation prevents stress‐induced enhancement of brain 5‐HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment
Raymond Mongeau, Cédric B. P. Martin, Caroline Chevarin, Rafael Maldonado, Michel Hamon, Patricia Robledo and Laurence Lanfumey Journal of Neurochemistry 115(2) 438 (2010) https://doi.org/10.1111/j.1471-4159.2010.06932.x
Eag 1, Eag 2 and Kcnn3 gene brain expression of isolated reared rats
S. Martin, C. Lino‐de‐Oliveira, S. R. L. Joca, R. Weffort de Oliveira, M. B. Echeverry, C. A. Da Silva, L. Pardo, W. Stühmer and E. D. Bel Genes, Brain and Behavior 9(8) 918 (2010) https://doi.org/10.1111/j.1601-183X.2010.00632.x
Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
Christian de Bodinat, Béatrice Guardiola-Lemaitre, Elisabeth Mocaër, et al. Nature Reviews Drug Discovery 9(8) 628 (2010) https://doi.org/10.1038/nrd3140
Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration
Differential effects of acute and repeated citalopram in mouse models of anxiety and depression
Cedric Mombereau, Tamar L. Gur, Jennifer Onksen and Julie A. Blendy The International Journal of Neuropsychopharmacology 13(03) 321 (2010) https://doi.org/10.1017/S1461145709990630
Constitutive Activity of Serotonin2C Receptors at G Protein-Independent Signaling: Modulation by RNA Editing and Antidepressants
Marilyne Labasque, Julie Meffre, Gaelle Carrat, Carine Becamel, Joël Bockaert and Philippe Marin Molecular Pharmacology 78(5) 818 (2010) https://doi.org/10.1124/mol.110.066035
GPCR Interacting Proteins (GIPs) in the Nervous System: Roles in Physiology and Pathologies
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: Interaction studies with citalopram
An immunocapture/scintillation proximity analysis of Gαq/11 activation by native serotonin (5‐HT)2A receptors in rat cortex: Blockade by clozapine and mirtazapine
Overexpression of 5‐HT2C receptors in forebrain leads to elevated anxiety and hypoactivity
Atsuko Kimura, Paula L. Stevenson, Roderick N. Carter, Gavin MacColl, Karen L. French, J. Paul Simons, Raya Al‐Shawi, Valerie Kelly, Karen E. Chapman and Megan C. Holmes European Journal of Neuroscience 30(2) 299 (2009) https://doi.org/10.1111/j.1460-9568.2009.06831.x
The effects of the selective 5-HT2C receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats
Determination of 5-HT2Cagonist KKHQ80114 and KKHQ80109 in Rat Plasma and Urine by Gas-Chromatography/Mass Spectrometry
Hye-Yeon Im, Hye-Sil Park, Hyun-Ah Choo, Ae-Nim Pae and Oh-Seung Kwon Journal of Korean Pharmaceutical Sciences 39(5) 321 (2009) https://doi.org/10.4333/KPS.2009.39.5.32
Upregulation of 5-HT2C receptors in hippocampus of pilocarpine-induced epileptic rats: Antagonism by Bacopa monnieri
In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist
Gian Marco Leggio, Adeline Cathala, Maud Neny, Françoise Rouge‐Pont, Filippo Drago, Pier Vincenzo Piazza and Umberto Spampinato Journal of Neurochemistry 111(2) 614 (2009) https://doi.org/10.1111/j.1471-4159.2009.06356.x
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors
Behavioral Neurobiology of Anxiety and Its Treatment
C. Durant, D. Christmas and D. Nutt Current Topics in Behavioral Neurosciences, Behavioral Neurobiology of Anxiety and Its Treatment 2 303 (2009) https://doi.org/10.1007/7854_2009_8
Mechanisms Contributing to the Phase-Dependent Regulation of Neurogenesis by the Novel Antidepressant, Agomelatine, in the Adult Rat Hippocampus
Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138
Inverse Agonist and Neutral Antagonist Actions of Antidepressants at Recombinant and Native 5-Hydroxytryptamine2C Receptors: Differential Modulation of Cell Surface Expression and Signal Transduction
Benjamin Chanrion, Clotilde Mannoury la Cour, Sophie Gavarini, Mathieu Seimandi, Laurent Vincent, Jean-François Pujol, Joël Bockaert, Philippe Marin and Mark J. Millan Molecular Pharmacology 73(3) 748 (2008) https://doi.org/10.1124/mol.107.041574
